Universal-Beteiligungs- und Servicegesellschaft
XERS icon

Universal-Beteiligungs- und Servicegesellschaft’s Xeris Biopharma Holdings XERS Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,192
Closed -$82.3K – 2209
2026
Q1 		$82.3K Hold
14,192
– – ﹤0.01% 2031
2025
Q4 		$111K Buy
14,192
+1,037
+8% +$8.16K ﹤0.01% 2021
2025
Q3 		$107K Buy
+13,155
New +$87.4K ﹤0.01% 2053

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's XERS Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Xeris Biopharma Holdings (XERS) in Q2 2026, closing a stake of 14,192 shares — an estimated $82.3K sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in XERS in Q3 2025 and held it in 3 quarters. The position peaked at $111K in Q4 2025. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft reported no remaining Xeris Biopharma Holdings position as of Q2 2026 after selling out during the quarter.
  • Universal-Beteiligungs- und Servicegesellschaft sold 14,192 Xeris Biopharma Holdings shares in Q2 2026, an estimated $82.3K.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Xeris Biopharma Holdings in Q3 2025 and held it in 3 quarters.
  • Universal-Beteiligungs- und Servicegesellschaft's Xeris Biopharma Holdings position peaked at $111K in Q4 2025.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.